Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Possible explanations for why some countries were harder hit by the pandemic influenza virus in 2009 – a global mortality impact modeling study

Authors: Kathleen F. Morales, John Paget, Peter Spreeuwenberg

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

A global pandemic mortality study found prominent regional mortality variations in 2009 for Influenza A(H1N1)pdm09. Our study attempts to identify factors that explain why the pandemic mortality burden was high in some countries and low in others.

Methods

As a starting point, we identified possible risk factors worth investigating for Influenza A(H1N1)pdm09 mortality through a targeted literature search. We then used a modeling procedure (data simulations and regression models) to identify factors that could explain differences in respiratory mortality due to Influenza A(H1N1)pdm09. We ran sixteen models to produce robust results and draw conclusions. In order to assess the role of each factor in explaining differences in excess pandemic mortality, we calculated the reduction in between country variance, which can be viewed as an effect-size for each factor.

Results

The literature search identified 124 publications and 48 possible risk factors, of which we were able to identify 27 factors with appropriate global datasets. The modelling procedure indicated that age structure (explaining 40% of the mean between country variance), latitude (8%), influenza A and B viruses circulating during the pandemic (3–8%), influenza A and B viruses circulating during the preceding influenza season (2–6%), air pollution (pm10; 4%) and the prevalence of other infections (HIV and TB) (4–6%) were factors that explained differences in mortality around the world. Healthcare expenditure, levels of obesity, the distribution of antivirals, and air travel did not explain global pandemic mortality differences.

Conclusions

Our study found that countries with a large proportion of young persons had higher pandemic mortality rates in 2009. The co-circulation of influenza viruses during the pandemic and the circulation of influenza viruses during the preceding season were also associated with pandemic mortality rates. We found that real time assessments of 2009 pandemic mortality risk factors (e.g. obesity) probably led to a number of false positive findings.
Appendix
Available only for authorised users
Literature
1.
go back to reference Influenza-like illness in the United States and Mexico. Geneva, World Health Organization, 24 April 2009, WHO, Editor. 2009. Influenza-like illness in the United States and Mexico. Geneva, World Health Organization, 24 April 2009, WHO, Editor. 2009.
2.
go back to reference Chowell, G., Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010. Comput Math Methods Med. 2012;2012:914196. Chowell, G., Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010. Comput Math Methods Med. 2012;2012:914196.
3.
go back to reference Lee EH, et al. Fatalities associated with the 2009 H1N1 influenza a virus in New York city. Clin Infect Dis. 2010;50(11):1498–504.CrossRefPubMed Lee EH, et al. Fatalities associated with the 2009 H1N1 influenza a virus in New York city. Clin Infect Dis. 2010;50(11):1498–504.CrossRefPubMed
4.
go back to reference Morgan OW, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza a(H1N1) disease. PLoS One. 2010;5(3):e9694.CrossRefPubMedPubMedCentral Morgan OW, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza a(H1N1) disease. PLoS One. 2010;5(3):e9694.CrossRefPubMedPubMedCentral
5.
go back to reference Santa-Olalla Peralta P, et al. Critically ill patients with 2009 pandemic influenza A (H1N1) infection in Spain: factors associated with death, April 2009 - Januari 2010. Rev Esp Publica. 2010;84(5):547–67. Santa-Olalla Peralta P, et al. Critically ill patients with 2009 pandemic influenza A (H1N1) infection in Spain: factors associated with death, April 2009 - Januari 2010. Rev Esp Publica. 2010;84(5):547–67.
6.
go back to reference Stein M, et al. Hospitalization of children with influenza a(H1N1) virus in Israel during the 2009 outbreak in Israel: a multicenter survey. Arch Pediatr Adolesc Med. 2010;164(11):1015–22.CrossRefPubMed Stein M, et al. Hospitalization of children with influenza a(H1N1) virus in Israel during the 2009 outbreak in Israel: a multicenter survey. Arch Pediatr Adolesc Med. 2010;164(11):1015–22.CrossRefPubMed
7.
go back to reference Louie JK, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza a (H1N1). Clin Infect Dis. 2011;52(3):301–12.CrossRefPubMed Louie JK, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza a (H1N1). Clin Infect Dis. 2011;52(3):301–12.CrossRefPubMed
9.
go back to reference Okada T, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother. 2011;17(2):238–45.CrossRefPubMed Okada T, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother. 2011;17(2):238–45.CrossRefPubMed
10.
go back to reference Steel J, Palese P, Lowen AC. Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain. J Virol. 2011;85(3):1400–2.CrossRefPubMed Steel J, Palese P, Lowen AC. Transmission of a 2009 pandemic influenza virus shows a sensitivity to temperature and humidity similar to that of an H3N2 seasonal strain. J Virol. 2011;85(3):1400–2.CrossRefPubMed
11.
go back to reference Blanton L, et al. Neurologic disorders among pediatric deaths associated with the 2009 pandemic influenza. Pediatrics. 2012;130(3):390–6.CrossRefPubMed Blanton L, et al. Neurologic disorders among pediatric deaths associated with the 2009 pandemic influenza. Pediatrics. 2012;130(3):390–6.CrossRefPubMed
12.
go back to reference Cordero E, et al. Immunosuppressed patients with pandemic influenza a 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis. 2012;31(4):547–56.CrossRefPubMed Cordero E, et al. Immunosuppressed patients with pandemic influenza a 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis. 2012;31(4):547–56.CrossRefPubMed
13.
go back to reference Louie JK, et al. Children hospitalized with 2009 novel influenza a(H1N1) in California. Arch Pediatr Adolesc Med. 2010;164(11):1023–31.CrossRefPubMed Louie JK, et al. Children hospitalized with 2009 novel influenza a(H1N1) in California. Arch Pediatr Adolesc Med. 2010;164(11):1023–31.CrossRefPubMed
15.
go back to reference Yung M, et al. Pandemic H1N1 in children requiring intensive care in Australia and New Zealand during winter 2009. Pediatrics. 2011;127(1):e156–63.CrossRefPubMed Yung M, et al. Pandemic H1N1 in children requiring intensive care in Australia and New Zealand during winter 2009. Pediatrics. 2011;127(1):e156–63.CrossRefPubMed
16.
go back to reference Cox CM, et al. 2009 pandemic influenza a (H1N1) deaths among children--United States, 2009-2010. Clin Infect Dis. 2011;52(Suppl 1):S69–74.CrossRefPubMed Cox CM, et al. 2009 pandemic influenza a (H1N1) deaths among children--United States, 2009-2010. Clin Infect Dis. 2011;52(Suppl 1):S69–74.CrossRefPubMed
17.
go back to reference Molbak K, et al. Burden of illness of the 2009 pandemic of influenza a (H1N1) in Denmark. Vaccine. 2011;29(Suppl 2):B63–9.CrossRefPubMed Molbak K, et al. Burden of illness of the 2009 pandemic of influenza a (H1N1) in Denmark. Vaccine. 2011;29(Suppl 2):B63–9.CrossRefPubMed
19.
go back to reference Vaillant L, et al. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009;14(33). Vaillant L, et al. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009;14(33).
20.
go back to reference Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med. 2010;38(4 Suppl):e52–7.CrossRefPubMed Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med. 2010;38(4 Suppl):e52–7.CrossRefPubMed
21.
go back to reference Pebody RG, et al. Pandemic influenza a (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to march 2010. Euro Surveill, 2010. 15(20). Pebody RG, et al. Pandemic influenza a (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to march 2010. Euro Surveill, 2010. 15(20).
22.
go back to reference Pramanick A, et al. Pandemic (H1N1) 2009 virus infection during pregnancy in South India. Int J Gynaecol Obstet. 2011;113(1):32–5.CrossRefPubMed Pramanick A, et al. Pandemic (H1N1) 2009 virus infection during pregnancy in South India. Int J Gynaecol Obstet. 2011;113(1):32–5.CrossRefPubMed
23.
go back to reference Shrestha SS, et al. Estimating the burden of 2009 pandemic influenza a (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis. 2011;52(Suppl 1):S75–82.CrossRefPubMed Shrestha SS, et al. Estimating the burden of 2009 pandemic influenza a (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis. 2011;52(Suppl 1):S75–82.CrossRefPubMed
24.
go back to reference Nikolopoulos G, et al. An ecological study of the determinants of differences in 2009 pandemic influenza mortality rates between countries in Europe. PLoS One. 2011;6(5):e19432. doi:10.1371/journal.pone.0019432. Nikolopoulos G, et al. An ecological study of the determinants of differences in 2009 pandemic influenza mortality rates between countries in Europe. PLoS One. 2011;6(5):e19432. doi:10.​1371/​journal.​pone.​0019432.
25.
go back to reference Shaman J, Goldstein E, Lipsitch M. Absolute humidity and pandemic versus epidemic influenza. Am J Epidemiology. 2011;173(2):127–35.CrossRef Shaman J, Goldstein E, Lipsitch M. Absolute humidity and pandemic versus epidemic influenza. Am J Epidemiology. 2011;173(2):127–35.CrossRef
26.
27.
go back to reference Van Kerkhove MD, Mounts AW. 2009 versus 2010 comparison of influenza activity in southern hemisphere temperate countries. Influenza Other Respir Viruses. 2011;5(6):375–9.CrossRefPubMed Van Kerkhove MD, Mounts AW. 2009 versus 2010 comparison of influenza activity in southern hemisphere temperate countries. Influenza Other Respir Viruses. 2011;5(6):375–9.CrossRefPubMed
28.
go back to reference Xu Z, et al. Air pollution, temperature and pediatric influenza in Brisbane, Australia. Environ Int. 2013;59C:384–8.CrossRef Xu Z, et al. Air pollution, temperature and pediatric influenza in Brisbane, Australia. Environ Int. 2013;59C:384–8.CrossRef
29.
go back to reference Viasus D, et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect. 2011;17(5):738–46.CrossRefPubMed Viasus D, et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect. 2011;17(5):738–46.CrossRefPubMed
30.
go back to reference Torres JP, et al. Impact of the novel influenza a (H1N1) during the 2009 autumn-winter season in a large hospital setting in Santiago, Chile. Clin Infect Dis. 2010;50(6):860–8.CrossRefPubMed Torres JP, et al. Impact of the novel influenza a (H1N1) during the 2009 autumn-winter season in a large hospital setting in Santiago, Chile. Clin Infect Dis. 2010;50(6):860–8.CrossRefPubMed
31.
go back to reference Miller PE, et al. Supply of neuraminidase inhibitors related to reduced influenza a (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study. PLoS One. 2012;7(9):e43491.CrossRefPubMedPubMedCentral Miller PE, et al. Supply of neuraminidase inhibitors related to reduced influenza a (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study. PLoS One. 2012;7(9):e43491.CrossRefPubMedPubMedCentral
32.
go back to reference Saidel-Odes L, et al. Risk factors for community-acquired pneumonia with influenza a/H1N1 in southern Israel. Int J Infect Dis. 2011;15(7):e470–4.CrossRefPubMed Saidel-Odes L, et al. Risk factors for community-acquired pneumonia with influenza a/H1N1 in southern Israel. Int J Infect Dis. 2011;15(7):e470–4.CrossRefPubMed
33.
34.
go back to reference Wilking H, et al. Mortality of 2009 pandemic influenza a(H1N1) in Germany. Euro Surveill. 2010;15(49). Wilking H, et al. Mortality of 2009 pandemic influenza a(H1N1) in Germany. Euro Surveill. 2010;15(49).
35.
go back to reference Schuchat A, Bell BP, Redd SC. The science behind preparing and responding to pandemic influenza: the lessons and limits of science. Clin Infect Dis. 2011;52(Suppl 1):S8–12.CrossRefPubMed Schuchat A, Bell BP, Redd SC. The science behind preparing and responding to pandemic influenza: the lessons and limits of science. Clin Infect Dis. 2011;52(Suppl 1):S8–12.CrossRefPubMed
36.
go back to reference Hosseini P. Predictive power of air travel and socio-economic data for early pandemic spread. PlosOne. 2010;5(9):e12763.CrossRef Hosseini P. Predictive power of air travel and socio-economic data for early pandemic spread. PlosOne. 2010;5(9):e12763.CrossRef
37.
go back to reference Li, Y., et al., Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med, 2013. Li, Y., et al., Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med, 2013.
38.
go back to reference Van Kerkhove MD, et al. Epidemiologic and virologic assessment of the 2009 influenza a (H1N1) pandemic on selected temperate countries in the southern hemisphere: Argentina, Australia, Chile, New Zealand and South Africa. Influenza Other Respir Viruses. 2011;5(6):e487–98.CrossRefPubMed Van Kerkhove MD, et al. Epidemiologic and virologic assessment of the 2009 influenza a (H1N1) pandemic on selected temperate countries in the southern hemisphere: Argentina, Australia, Chile, New Zealand and South Africa. Influenza Other Respir Viruses. 2011;5(6):e487–98.CrossRefPubMed
40.
go back to reference Van Kerkhove MD, et al. Risk factors for severe outcomes following 2009 influenza a (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8(7):e1001053.CrossRefPubMedPubMedCentral Van Kerkhove MD, et al. Risk factors for severe outcomes following 2009 influenza a (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8(7):e1001053.CrossRefPubMedPubMedCentral
41.
go back to reference Simonsen L, et al. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013;10(11):e1001558. Simonsen L, et al. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013;10(11):e1001558.
43.
go back to reference Dawood FS, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza a H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12(9):687–95.CrossRefPubMed Dawood FS, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza a H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12(9):687–95.CrossRefPubMed
44.
go back to reference WHO Global Health Observatory Data Repository. World Health Organization; 2009. online. WHO Global Health Observatory Data Repository. World Health Organization; 2009. online.
45.
go back to reference The World Bank Open Data Database. The World Bank; 2009. online. The World Bank Open Data Database. The World Bank; 2009. online.
46.
go back to reference WHO FluNet Database. World Health Organization; 2009. online. WHO FluNet Database. World Health Organization; 2009. online.
47.
go back to reference The Global Asthma Report 2011. The International Union Against Tuberculosis and Lung Disease: online. The Global Asthma Report 2011. The International Union Against Tuberculosis and Lung Disease: online.
48.
go back to reference West SG, Thoemmes F. Campbell's and Rubin's perspectives on causal inference. Psychol Methods. 2010;15(1):18–37.CrossRefPubMed West SG, Thoemmes F. Campbell's and Rubin's perspectives on causal inference. Psychol Methods. 2010;15(1):18–37.CrossRefPubMed
49.
go back to reference Ahern J, Hubbard A, Galea S. Estimating the effects of potential public health interventions on population disease burden: a step-by-step illustration of causal inference methods. Am J Epidemiol. 2009;169(9):1140–7.CrossRefPubMedPubMedCentral Ahern J, Hubbard A, Galea S. Estimating the effects of potential public health interventions on population disease burden: a step-by-step illustration of causal inference methods. Am J Epidemiol. 2009;169(9):1140–7.CrossRefPubMedPubMedCentral
51.
go back to reference Cocoros, N.M., et al., Obesity as a risk factor for severe influenza-like illness. Influenza Other Respi Viruses, 2013. Cocoros, N.M., et al., Obesity as a risk factor for severe influenza-like illness. Influenza Other Respi Viruses, 2013.
52.
go back to reference Skarbinski J, et al. Hospitalized patients with 2009 pandemic influenza a (H1N1) virus infection in the United States--September-October 2009. Clin Infect Dis. 2011;52(Suppl 1):S50–9.CrossRefPubMed Skarbinski J, et al. Hospitalized patients with 2009 pandemic influenza a (H1N1) virus infection in the United States--September-October 2009. Clin Infect Dis. 2011;52(Suppl 1):S50–9.CrossRefPubMed
53.
go back to reference Rolland-Harris E, et al. Hospitalization of pregnant women with pandemic a(H1N1) 2009 influenza in Canada. Epidemiol Infect. 2012;140(7):1316–27.CrossRefPubMed Rolland-Harris E, et al. Hospitalization of pregnant women with pandemic a(H1N1) 2009 influenza in Canada. Epidemiol Infect. 2012;140(7):1316–27.CrossRefPubMed
54.
go back to reference Skowronski DM, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med. 2010;7(4):e1000258.CrossRefPubMedPubMedCentral Skowronski DM, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med. 2010;7(4):e1000258.CrossRefPubMedPubMedCentral
55.
go back to reference Viboud C, Simonsen L. Does seasonal influenza vaccination increase the risk of illness with the 2009 a/H1N1 pandemic virus? PLoS Med. 2010;7(4):e1000259.CrossRefPubMedPubMedCentral Viboud C, Simonsen L. Does seasonal influenza vaccination increase the risk of illness with the 2009 a/H1N1 pandemic virus? PLoS Med. 2010;7(4):e1000259.CrossRefPubMedPubMedCentral
56.
go back to reference Peters PJ, et al. HIV-infected hospitalized patients with 2009 pandemic influenza a (pH1N1)--United States, spring and summer 2009. Clin Infect Dis. 2011;52(Suppl 1):S183–8.CrossRefPubMed Peters PJ, et al. HIV-infected hospitalized patients with 2009 pandemic influenza a (pH1N1)--United States, spring and summer 2009. Clin Infect Dis. 2011;52(Suppl 1):S183–8.CrossRefPubMed
57.
go back to reference Sheth AN, Patel P, Peters PJ. Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic. Curr HIV/AIDS Rep. 2011;8(3):181–91.CrossRefPubMed Sheth AN, Patel P, Peters PJ. Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic. Curr HIV/AIDS Rep. 2011;8(3):181–91.CrossRefPubMed
58.
go back to reference Jefferson T, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4:CD008965. Jefferson T, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4:CD008965.
59.
go back to reference Jefferson T, et al. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014;348:g2545.CrossRefPubMedPubMedCentral Jefferson T, et al. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014;348:g2545.CrossRefPubMedPubMedCentral
60.
go back to reference Leung YH, et al. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus. Epidemiol Infect. 2012;140(5):814–7.CrossRefPubMed Leung YH, et al. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus. Epidemiol Infect. 2012;140(5):814–7.CrossRefPubMed
62.
go back to reference Button KS, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14(5):365–76.CrossRefPubMed Button KS, et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14(5):365–76.CrossRefPubMed
64.
go back to reference Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis. 2011;52(2):219–27.CrossRefPubMedPubMedCentral Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis. 2011;52(2):219–27.CrossRefPubMedPubMedCentral
65.
go back to reference Mickiene A, et al. Hospitalized adult patients with 2009 pandemic influenza a (H1N1) in Kaunas, Lithuania. Medicina (Kaunas). 2011;47(1):11–8. Mickiene A, et al. Hospitalized adult patients with 2009 pandemic influenza a (H1N1) in Kaunas, Lithuania. Medicina (Kaunas). 2011;47(1):11–8.
66.
go back to reference Suarez-Varela MM, et al. Pandemic influenza a (H1N1) infection in pregnant and nonpregnant women in Spain (2009-2010). Jpn J Infect Dis. 2014;67(3):163–71.CrossRefPubMed Suarez-Varela MM, et al. Pandemic influenza a (H1N1) infection in pregnant and nonpregnant women in Spain (2009-2010). Jpn J Infect Dis. 2014;67(3):163–71.CrossRefPubMed
67.
go back to reference Anderson BL, Rouse DJ, Fitzsimmons C. Clinical characteristics of pregnant women with influenza-like illness during the 2009 H1N1 pandemic and use of a standardized management algorithm. Am J Obstet Gynecol. 2011;204(6 Suppl 1):S31–7.CrossRefPubMedPubMedCentral Anderson BL, Rouse DJ, Fitzsimmons C. Clinical characteristics of pregnant women with influenza-like illness during the 2009 H1N1 pandemic and use of a standardized management algorithm. Am J Obstet Gynecol. 2011;204(6 Suppl 1):S31–7.CrossRefPubMedPubMedCentral
68.
go back to reference Poeppl W, et al. Clinical aspects of 2009 pandemic influenza a (H1N1) virus infection in Austria. Infection. 2011;39(4):341–52.CrossRefPubMed Poeppl W, et al. Clinical aspects of 2009 pandemic influenza a (H1N1) virus infection in Austria. Infection. 2011;39(4):341–52.CrossRefPubMed
69.
go back to reference Jamieson DJ, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374(9688):451–8.CrossRefPubMed Jamieson DJ, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374(9688):451–8.CrossRefPubMed
70.
go back to reference Jefferson T, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2012;1:CD008965.PubMed Jefferson T, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2012;1:CD008965.PubMed
71.
go back to reference Castrodale L, et al. Deaths related to 2009 pandemic influenza A(H1N1) among American Indian/Alaskan natives - 12 states, 2009. Morb Mortal Wkly Rep. 2009;48(48):1341–4. Castrodale L, et al. Deaths related to 2009 pandemic influenza A(H1N1) among American Indian/Alaskan natives - 12 states, 2009. Morb Mortal Wkly Rep. 2009;48(48):1341–4.
72.
go back to reference Ji W, et al. Characteristics and the prevalence of respiratory viruses and the correlation with climatic factors of hospitalized children in Suzhou children's hospital. Zhonghua Yu Fang Yi Xue Za Zhi. 2011;45(3):205–10.PubMed Ji W, et al. Characteristics and the prevalence of respiratory viruses and the correlation with climatic factors of hospitalized children in Suzhou children's hospital. Zhonghua Yu Fang Yi Xue Za Zhi. 2011;45(3):205–10.PubMed
Metadata
Title
Possible explanations for why some countries were harder hit by the pandemic influenza virus in 2009 – a global mortality impact modeling study
Authors
Kathleen F. Morales
John Paget
Peter Spreeuwenberg
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2730-0

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue